Skip to main content

Sarcoma

News
05/31/2020
A maintenance therapy regimen comprising oral cyclophosphamide plus celecoxib has demonstrated feasibility in patients with metastatic Ewing sarcoma.
A maintenance therapy regimen comprising oral cyclophosphamide plus celecoxib has demonstrated feasibility in patients with metastatic Ewing sarcoma.
A maintenance therapy regimen...
05/31/2020
Oncology
Conference Insider
05/29/2020
In a phase 2 study of patients with advanced epithelioid sarcoma, tazemetostat demonstrated durable clinical response and favorable safety.
In a phase 2 study of patients with advanced epithelioid sarcoma, tazemetostat demonstrated durable clinical response and favorable safety.
In a phase 2 study of patients...
05/29/2020
Oncology
Real-World Study Highlights Treatment, QOL Among US Patients With Diffuse-Type TGCT
Videos
05/27/2020
Claire Verschraegen, MD, comments on a real-world study examining the treatment and quality-of-life of patients with diffuse-type TGCT.
Claire Verschraegen, MD, comments on a real-world study examining the treatment and quality-of-life of patients with diffuse-type TGCT.
Claire Verschraegen, MD,...
05/27/2020
Oncology
Videos
09/12/2019
James Hu, MD, FACP, discusses the results of the ANNOUNCE Trial and challenges associated with treating sarcoma.
James Hu, MD, FACP, discusses the results of the ANNOUNCE Trial and challenges associated with treating sarcoma.
James Hu, MD, FACP, discusses...
09/12/2019
Oncology